Patterns of recurrence of early breast cancer according to estrogen receptor status: a therapeutic target for a quarter of a century-Reference-Cited by-同舟云学术

Patterns of recurrence of early breast cancer according to estrogen receptor status: a therapeutic target for a quarter of a century

Published:2009-01-10 Issue:2 Volume:117 Page:319-324
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Pagani Olivia, ,Price Karen N.,Gelber Richard D.,Castiglione-Gertsch Monica,Holmberg Stig B.,Lindtner Jurij,Thürlimann Beat,Collins John,Fey Martin F.,Coates Alan S.,Goldhirsch Aron

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10549-008-0282-0.pdf

Reference23 articles.

1. Goldhirsch A, Wood W, Gelber R et al (2007) Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer. Ann Oncol 18:1133–1144. doi: 10.1093/annonc/mdm271

2. Zava DT, Wyler-Von Ballmoos A, Goldhirsch A et al (1982) A quality control study to assess the inter-laboratory variability of routine estrogen and progesterone receptor assays. Eur J Cancer Clin Oncol 18:713–721. doi: 10.1016/0277-5379(82)90068-2

3. Jordan VC, Zava DT, Eppenberger U et al (1983) Reliability of steroid hormone receptor assays: an international study. Eur J Cancer Clin Oncol 19:357–363. doi: 10.1016/0277-5379(83)90133-5

4. Goldhirsch A, Coates AS, Gelber RD et al (2006) First select the target: better choice of adjuvant treatments for breast cancer patients. Ann Oncol 17:1772–1776. doi: 10.1093/annonc/mdl398

5. Early Breast Cancer Trialists’ Collaborative Group (2005) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 365:1687–1717. doi: 10.1016/S0140-6736(05)66544-0

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessing Mode of Recurrence in Breast Cancer to Identify an Optimised Follow-Up Pathway: 10-Year Institutional Review;Annals of Surgical Oncology;2023-07-21

2. Variation in second breast cancer risk after primary invasive cancer by time since primary cancer diagnosis and estrogen receptor status;Cancer;2023-02-15

3. Estimating the Benefit of Preoperative Systemic Therapy to Reduce the Extent of Breast Cancer Surgery: Current Standard and Future Directions;Cancer Treatment and Research;2023

4. The Utility of Breast Cancer Index (BCI) Over Clinical Prognostic Tools for Predicting the Need for Extended Endocrine Therapy: A Safety Net Hospital Experience;Clinical Breast Cancer;2022-12

5. Obstetric and Neonatal Outcomes 1 or More Years After a Diagnosis of Breast Cancer;Obstetrics & Gynecology;2022-11-02